Norethindrone

Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.

Cross Reference

Introduction

To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Norethindrone?

Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Norethindrone

MeSH term MeSH ID Detail
Pancreatic Neoplasms D010190 77 associated lipids
Body Weight D001835 333 associated lipids
Arteriosclerosis D001161 86 associated lipids
Total 3

PubChem Associated disorders and diseases

What pathways are associated with Norethindrone

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Norethindrone?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Norethindrone?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Norethindrone?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Norethindrone?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Norethindrone?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Norethindrone

Download all related citations
Per page 10 20 50 100 | Total 3869
Authors Title Published Journal PubMed Link
Walle T et al. Stimulatory as well as inhibitory effects of ethinyloestradiol on the metabolic clearances of propranolol in young women. 1996 Br J Clin Pharmacol pmid:8730976
Chitlange SM et al. Ultrasonographic monitoring of ovarian follicles in women using norethisterone for contraception. 1996 Int J Gynaecol Obstet pmid:8737301
Martinez OB and Roe DA Lack of effect of norethindrone and mestranol on folacin depletion and repletion in rats. 1977 J. Nutr. pmid:874560
Wide L et al. Time-related effects of a progestogen on the isoforms of serum gonadotrophins in 17 beta-oestradiol treated post-menopausal women. 1996 Clin. Endocrinol. (Oxf) pmid:8759177
Tu N et al. [Effects of sexual hormone anticoncipiens on periodontal tissue]. 1995 Zhonghua Kou Qiang Yi Xue Za Zhi pmid:8762540
Wilhelm JL and Scommegna A Catamenial pneumothorax. Bilateral occurrence while on suppressive therapy. 1977 Obstet Gynecol pmid:876563
Lahdenperä S et al. Effects of postmenopausal estrogen/progestin replacement therapy on LDL particles; comparison of transdermal and oral treatment regimens. 1996 Atherosclerosis pmid:8769679
Graff-Iversen S et al. Cardiovascular risk factors in Norwegian women using oral contraceptives: results from a cardiovascular health screening 1985-88. 1996 Contraception pmid:8773420
Pommier F et al. Simultaneous determination of norethisterone and six metabolites in human plasma by capillary gas chromatography with mass-selective detection. 1995 J. Chromatogr. B, Biomed. Appl. pmid:8788144
Evans SF and Davie M Added effect of progestogens on bone mineral density response to oestrogen. 1996 Clin. Endocrinol. (Oxf) pmid:8796150
Marchesoni D et al. Transdermal estroprogestins versus transdermal estrogen plus oral dihydrogesterone replacement in menopause. 1996 J. Endocrinol. Invest. pmid:8796334
Back DJ et al. The pharmacokinetics of norethisterone in the rabbit and rat after systemic and oral administration: effect of phenobarbitone [proceedings]. 1977 Br. J. Pharmacol. pmid:880448
Jeyaseelan S et al. Local tissue response to silastic implant containing norethindrone acetate in women. 1977 Contraception pmid:880802
Kulkarni BD et al. Steroid contraceptives in non-human primates (II). Metabolic fate of synthetic estrogens in the baboon after exposure to oral contraceptives. 1977 Contraception pmid:880810
Hillier SG et al. Long-term contraception by steroid releasing implants. VI. Serum concentrations of norethindrone in women bearing a single silastic implant releasing norethindrone acetate. 1977 Contraception pmid:880821
Multinational comparative clinical evaluation of two long-acting injectable contraceptive steroids: norethisterone oenanthate and medroxyprogesterone acetate. 1. Use-effectiveness. 1977 Contraception pmid:880823
Görög S et al. Analysis of steroids Part 50. Derivatization of ketosteroids for their separation and determination by capillary electrophoresis. 1996 J Pharm Biomed Anal pmid:8818023
Valette A et al. Norethindrone stimulates in vivo glycosyltransferases in the rat liver. 1996 Horm. Metab. Res. pmid:8820994
Brügmann E et al. [Liver function studies under the influence of hormonal contraceptives (sequential preparations)]. 1979 Dtsch Z Verdau Stoffwechselkr pmid:88322
Görög S et al. Estimation of impurity profiles of drugs and related materials. Part 14: the role of HPLC/diode-array UV spectroscopy in the identification of minor components (impurities, degradation products, metabolites) in various matrices. 1995 J Pharm Biomed Anal pmid:8833970
Pasapera AM et al. In vitro molecular assessment of the mechanisms of action of 19-nor progestins used as contragestational agents. 1995 Arch. Med. Res. pmid:8845651
Friedrich E [The effect of low dose gestagens on the hypothalamic-pituitary-ovarian axis]. 1977 Fortschr. Med. pmid:885464
Taskinen MR et al. Hormone replacement therapy lowers plasma Lp(a) concentrations. Comparison of cyclic transdermal and continuous estrogen-progestin regimens. 1996 Arterioscler. Thromb. Vasc. Biol. pmid:8857916
Stadberg E et al. 17 beta-estradiol and norethisterone acetate in low doses as continuous combined hormone replacement therapy. 1996 Maturitas pmid:8861084
Farish E et al. Effects of postmenopausal hormone replacement therapy on lipoproteins including lipoprotein(a) and LDL subfractions. 1996 Atherosclerosis pmid:8879436
Hill PV Tubal pregnancy despite oral contraception. 1977 S. Afr. Med. J. pmid:888044
Istre O et al. Hormone replacement therapy after transcervical resection of the endometrium. 1996 Obstet Gynecol pmid:8885910
Speroff L et al. The comparative effect on bone density, endometrium, and lipids of continuous hormones as replacement therapy (CHART study). A randomized controlled trial. 1996 JAMA pmid:8892714
Howard G et al. The effects of intramuscular norethisterone oenanthate used as a contraceptive on intravenous glucose tolerance and on blood coagulation factors VII and X. 1977 Br J Obstet Gynaecol pmid:889752
Dören M and Schneider HP Long-term compliance of continuous combined estrogen and progestogen replacement in postmenopausal women. 1996 Maturitas pmid:8905600
Hermans C et al. More on gastric antral vascular ectasia (watermelon stomach) in uremic patients. 1996 Sep-Oct Perit Dial Int pmid:8914187
Cédrin-Durnerin I et al. The hormonal flare-up following gonadotrophin-releasing hormone agonist administration is influenced by a progestogen pretreatment. 1996 Hum. Reprod. pmid:8921054
Eiken P et al. Effect of 10 years' hormone replacement therapy on bone mineral content in postmenopausal women. 1996 Bone pmid:8922661
Oon CJ et al. Hepatocellular carcinoma in a patient on oral contraception who had been exposed to hepatitis B virus. 1979 Lancet pmid:89298
Wu JY Collaborative study of an assay for progestational steroids in individual contraceptive tablets. 1977 J Assoc Off Anal Chem pmid:893310
Pommier F et al. Quantitative determination of norethisterone acetate in human plasma by capillary gas chromatography with mass-selective detection. 1996 J Chromatogr A pmid:8938383
Raymond EG et al. Contraceptive efficacy, pharmacokinetics, and safety of Annuelle biodegradable norethindrone pellet implants. 1996 Fertil. Steril. pmid:8941061
Imthurn B et al. Effect of a programmed short-term stimulation protocol on the replacement of cryopreserved embryos. 1996 J. Assist. Reprod. Genet. pmid:8947818
Thom MH et al. Prevention and treatment of endometrial disease in climacteric women receiving oestrogen therapy. 1979 Lancet pmid:89511
Serup J et al. Natural oestrogens for oral contraception. 1979 Lancet pmid:89531
Couzinet B et al. The antigonadotropic activity of progestins (19-nortestosterone and 19-norprogesterone derivatives) is not mediated through the androgen receptor. 1996 J. Clin. Endocrinol. Metab. pmid:8954018
Mueck AO et al. Urinary cGMP excretion after hormone replacement therapy in postmenopausal women. 1996 Exp. Clin. Endocrinol. Diabetes pmid:8957275
Kovacs G Progestogen-only pills and bleeding disturbances. 1996 Hum. Reprod. pmid:8982741
Wonodirekso S et al. Cytokeratin 8, 18 and 19 in endometrial epithelium of Norplant and norethisterone enanthate injectable progestogen contraceptive users. 1996 Hum. Reprod. pmid:8982756
Viinikka L et al. Different effects of oral and transdermal hormonal replacement on prostacyclin and thromboxane A2. 1997 Obstet Gynecol pmid:8990448
Voigt R et al. [Clinical studies on the effect of long term progestagen administration on the elimination of noramidopyrine methanesulfonate (Analgin)]. 1977 Zentralbl Gynakol pmid:899364
Perry HD and Mallen FJ Cilioretinal artery occlusion associated with oral contraceptives. 1977 Am. J. Ophthalmol. pmid:900218
Schmit A et al. Diagnostic efficacy of push-enteroscopy and long-term follow-up of patients with small bowel angiodysplasias. 1996 Dig. Dis. Sci. pmid:9011441
Singh M et al. Biodegradable norethindrone (NET:cholesterol) contraceptive implants: phase II-A: a clinical study in women. 1997 Contraception pmid:9013058
Nenseter MS et al. Effect of hormone replacement therapy on the susceptibility of low-density lipoprotein to oxidation among postmenopausal hypercholesterolaemic women. 1996 Eur. J. Clin. Invest. pmid:9013080
White IN and Muller-Eberhard U Decreased liver cytochrome P-450 in rats caused by norethindrone or ethynyloestradiol. 1977 Biochem. J. pmid:901418
Smith AM Choice of oestrogen/progestagen regimen, for symptoms of the climacteric. 1979 Lancet pmid:90284
Nathorst-Böös J and Hammar M Effect on sexual life--a comparison between tibolone and a continuous estradiol-norethisterone acetate regimen. 1997 Maturitas pmid:9032742
Helle SI et al. Effects of oral and transdermal oestrogen replacement therapy on plasma levels of insulin-like growth factors and IGF binding proteins 1 and 3: a cross-over study. 1996 Clin. Endocrinol. (Oxf) pmid:9039339
Klaiber EL et al. Individual differences in changes in mood and platelet monoamine oxidase (MAO) activity during hormonal replacement therapy in menopausal women. 1996 Psychoneuroendocrinology pmid:9044441
Bozhinova S [The use of the Norcolut preparation in gynecologic; practice]. 1996 Akush Ginekol (Sofiia) pmid:9045566
Ditkoff EC et al. The addition of norethindrone acetate to leuprolide acetate for ovarian suppression has no adverse effect on ovarian stimulation. 1997 J. Assist. Reprod. Genet. pmid:9048239
McCune GS The need for systematic reviews in the treatment of menstrual disorders--another Cochrane collaborative review group is born. 1997 Br J Obstet Gynaecol pmid:9070156
Coulter A and Sheldon T The need for systematic reviews in the treatment of menstrual disorders--another Cochrane collaborative review group is born. 1997 Br J Obstet Gynaecol pmid:9070157
Rosenfeld WE et al. Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy. 1997 Epilepsia pmid:9070594
Patton DL et al. Oral contraceptives do not alter the course of experimentally induced chlamydial salpingitis in monkeys. 1994 Mar-Apr Sex Transm Dis pmid:9071418
Tilly-Kiesi M et al. Responses of HDL subclasses, Lp(A-I) and Lp(A-I:A-II) levels and lipolytic enzyme activities to continuous oral estrogen-progestin and transdermal estrogen with cyclic progestin regimens in postmenopausal women. 1997 Atherosclerosis pmid:9105568
Mueck AO et al. Influence of norethisterone acetate and estradiol on the serotonin metabolism of postmenopausal women. 1997 Horm. Metab. Res. pmid:9105905
Schwingl PJ and Shelton J Modeled estimates of myocardial infarction and venous thromboembolic disease in users of second and third generation oral contraceptives. 1997 Contraception pmid:9114999
Seeking new methods. 1977 People pmid:913851
Hanson RM and Melzer DJ Estrogen replacement therapy: new options, continuing concerns. 1997 JAMA pmid:9153359
Greyling MD et al. Ligand specificity of uterine oestrogen and progesterone receptors in the subadult African elephant, Loxodonta africana. 1997 J. Reprod. Fertil. pmid:9155728
Saxena BN et al. Radioimmunoassay of serum norethisterone oenanthate levels in women after intramuscular administration. 1977 J. Steroid Biochem. pmid:916668
Chryssikopoulos A et al. Cyclic and individualized administration of gonadotropin-releasing hormone agonists plus progestogens: an alternative protocol for contraception. 1997 Gynecol. Endocrinol. pmid:9174853
Singh M et al. Contraceptive efficacy of norethindrone encapsulated in injectable biodegradable poly-dl-lactide-co-glycolide microspheres (NET-90): phase III clinical study. 1997 Adv Contracept pmid:9181181
Herz JE et al. Preparation of 19-nor-17alpha-ethinyltestosterone pivalate ester. 1977 Steroids pmid:919011
Moretti G et al. [Simultaneous determination using gas chromatography of mestranol and norethisterone in estrogen-progestins combination for oral use]. 1977 Boll Chim Farm pmid:921851
Benagiano G et al. Comparative clinical evaluation of the effect on carbohydrate and lipid metabolism of two norethisterone-containing hormonal contraceptives: Mesigyna and TriNovum. 1997 Contraception pmid:9220226
Diffey B et al. The effect of oral contraceptive agents on the basal metabolic rate of young women. 1997 Br. J. Nutr. pmid:9227183
Seth U et al. Effect of a subdermal silastic implant containing norethindrone acetate on human lactation. 1977 Contraception pmid:923249
Saleh FM Serium protein-bound carbohydrate and seromucoid levels during long-acting progestational contraceptive therapy. 1977 Contraception pmid:923250
Saleh FM and Abd-el-Hay MM Liver function tests after the use of long-acting progestational contraceptives. 1977 Contraception pmid:923251
Laumas KR Recent progress in the development of long-acting injectables for control of human fertility. 1977 J Obstet Gynaecol India pmid:923990
Litschgi M and Glatthaar E [A casuistic contribution to therapy with gestagen in metastasizing corpus carcinoma (author's transl)]. 1977 Geburtshilfe Frauenheilkd pmid:924094
Haapasaari KM et al. Systemic therapy with estrogen or estrogen with progestin has no effect on skin collagen in postmenopausal women. 1997 Maturitas pmid:9255750
Alfie J et al. Hemodynamic effects of transdermal estradiol alone and combined with norethisterone acetate. 1997 Maturitas pmid:9255751
Hess FM et al. Effect of low zinc intake and oral contraceptive agents on nitrogen utilization and clinical findings in young women. 1977 J. Nutr. pmid:925768
Ravinder P et al. Pharmacokinetics of orally administered norethisterone enanthate in rabbit, monkey, and women. 1997 Contraception pmid:9262934
Rossmanith WG et al. A comparative randomized trial on the impact of two low-dose oral contraceptives on ovarian activity, cervical permeability, and endometrial receptivity. 1997 Contraception pmid:9306028
Jasonni VM et al. Transdermal progestins in hormone replacement therapy. 1997 Ann. N. Y. Acad. Sci. pmid:9329856
Haines CJ et al. Sonographic measurement of endometrial thickness as a predictor of vaginal bleeding in women using continuous combined hormone replacement therapy. 1997 Gynecol. Obstet. Invest. pmid:9359646
Kullander S and Källén B A prospective study of drugs and pregnancy. 3. Hormones. 1976 Acta Obstet Gynecol Scand pmid:936986
Herbai G and Werner I Sheehan's syndrome of hypothalamic origin in a woman with juvenile diabetes mellitus. 1976 Acta Med Scand pmid:937082
Wiese J et al. Long-term contraception with norethindrone subcutaneous capsules. 1976 Ann. Clin. Res. pmid:937998
Marcucci F et al. Effect of estrogen-progestin combinations on the hepatic microsomal metabolism of mestranol. 1976 Biochem. Pharmacol. pmid:938556
Ulrich LG et al. Quality of life and patient preference for sequential versus continuous combined HRT: the UK Kliofem multicenter study experience. UK Continuous Combined HRT Study Investigators. 1997 Int J Gynaecol Obstet pmid:9386211
Mc Manus J et al. The effect of hormone replacement therapy on the oxidation of low density lipoprotein in postmenopausal women. 1997 Atherosclerosis pmid:9395275
Beier S et al. The progestational activity of different gestagens used for human contraception in the beagle bitch. 1979 Contraception pmid:94000
De Aguilar MA et al. Current status of injectable hormonal contraception, with special reference to the monthly method. 1997 Adv Contracept pmid:9404550
Comparative study of the effects of two once-a-month injectable steroidal contraceptives (Mesigyna and Cyclofem) on lipid and lipoprotein metabolism. United Nations Development Programme/United Nations Population Fund/World Health Organization/World Bank, Special Programme of Research, Development and Research Training in Human Reproduction. 1997 Contraception pmid:9408700
Weisberg E et al. Effect of different insertion regimens on side effects with a combination contraceptive vaginal ring. 1997 Contraception pmid:9408704
Shetty G et al. Use of norethisterone and estradiol in mini doses as a contraceptive in the male. Efficacy studies in the adult male bonnet monkey (Macaca radiata). 1997 Contraception pmid:9408708
Dickey RP et al. Estrogen potencies of three new low-dose oral contraceptives. 1976 Am. J. Obstet. Gynecol. pmid:941952
Andersen RN et al. Response of the binding capacity of plasma testosterone-estradiol-binding globulin to norethindrone, 2 mg., and mestranol, 0.1 mg., in polycystic ovarian disease. 1976 Am. J. Obstet. Gynecol. pmid:944533
Hyder SM et al. Progestin regulation of vascular endothelial growth factor in human breast cancer cells. 1998 Cancer Res. pmid:9458078